HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results Highlights of the fiscal year include: • Revenue of $999.6 million, an increase of 16$861.7 million in FY23. • Net income of $55.7 million, compared to net loss of$26.1 million in FY23, with non-GAAP net income of $195.5 million, compared to$114.5 million in FY23. • Net income per diluted share of $0.64, compared to net loss per diluted share of$0.31 in FY23, with non-GAAP net income per diluted sha ...